K2 HealthVentures completed the acquisition of VBI Vaccines.

Synopsis

K2 HealthVentures, a venture capital firm, completed the acquisition of VBI Vaccines, a biopharmaceutical company developing vaccine and immunotherapeutic candidates. Financial terms were not disclosed.

Principals

target

Vbi Vaccines

bidder

K2 Healthventures

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

stikeman elliott

HQ - Montreal

legal advisors

target

553

Deals

£ 439.16 B

Total Value

mcmillan

HQ - Vancouver

legal advisors

bidder

Deals

£ 13.92 B

Total Value